Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Gastroenterology
•
Allergy & Immunology
•
Mast Cell Disorders
•
Gastrointestinal Functional & Motility Disorders
•
General Gastroenterology
How do you counsel a patient on returning to the care of their PCP when a workup for MCAS has been unrevealing, but the patient insists that they have a mast cell disorder because they respond to antihistamine therapy?
Related Questions
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How would you approach the treatment of a patient with solid food esophageal dysphagia and GERD without a detectable esophageal stricture on upper endoscopy?
How do you use gut microbiome or gut microbiota analysis in your clinical practice, if at all?
How would you approach management of a patient with a medium-to-large vessel vasculitis who developed perforation of the stomach and colon on steroids and cyclophosphamide?
What recommendations do you provide to advance an inpatient’s oral tolerance in the setting of an unspecified vomiting disorder?
How would you treat blue rubber bleb nevus syndrome?
Do you diagnose MCAS if a patient is concurrently on drugs known to cause non-specific mast cell degranulation?
What inpatient diagnostic workup do you pursue in a patient with an unspecified vomiting disorder who cannot be discharged due to poor PO tolerance?
Is there a particular prokinetic agent that you recommend if a patient has failed both PPI and TCA in the treatment of suspected functional dyspepsia?
How do you approach managing nausea and GI side effects when initiating methotrexate?
